Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer

Marco Giallombardo, Pablo Reclusa Asiain, Christian Rolfo, Crispi, Camps, Marco Giallombardo, Anna Valentino, Patrick Pauwels, Rafael Sirera, Pablo Reclusa

Risultato della ricerca: Article

25 Citazioni (Scopus)

Abstract

Prostate cancer is the second most diagnosed cancer in males in the world. Plasma quantification of prostate-specific antigen substantially improved the early detection of prostate cancer, but still lacks the required specificity. Clinical management of prostate cancer needs advances in the development of new non-invasive biomarkers, ameliorating current diagnosis and prognosis and guiding therapeutic decisions. microRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the post-transcriptional level. These miRNAs are expressed in the cells and are also present in cell-derived extracellular vesicles such as exosomes. Exosomes have been shown to act as mediators for cell to cell communication because of the regulatory functions of their content. High levels of exosomes are found in several body fluids from cancer patients and could be a potential source of non-invasive biomarkers. In this review, we summarize the diagnostic and prognostic utility of exosomal miRNAs in prostate cancer.
Lingua originaleEnglish
pagine (da-a)651-657
Numero di pagine7
RivistaCLINICAL & TRANSLATIONAL ONCOLOGY.
Volume19
Stato di pubblicazionePublished - 2017

Fingerprint

Exosomes
MicroRNAs
Prostatic Neoplasms
Biomarkers
Biopsy
Small Untranslated RNA
Body Fluids
Prostate-Specific Antigen
Early Detection of Cancer
Cell Communication
Neoplasms
Gene Expression
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cita questo

Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer. / Giallombardo, Marco; Reclusa Asiain, Pablo; Rolfo, Christian; Crispi; Camps; Giallombardo, Marco; Valentino, Anna; Pauwels, Patrick; Sirera, Rafael; Reclusa, Pablo.

In: CLINICAL & TRANSLATIONAL ONCOLOGY., Vol. 19, 2017, pag. 651-657.

Risultato della ricerca: Article

Giallombardo, M, Reclusa Asiain, P, Rolfo, C, Crispi, Camps, Giallombardo, M, Valentino, A, Pauwels, P, Sirera, R & Reclusa, P 2017, 'Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer', CLINICAL & TRANSLATIONAL ONCOLOGY., vol. 19, pagg. 651-657.
Giallombardo, Marco ; Reclusa Asiain, Pablo ; Rolfo, Christian ; Crispi ; Camps ; Giallombardo, Marco ; Valentino, Anna ; Pauwels, Patrick ; Sirera, Rafael ; Reclusa, Pablo. / Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer. In: CLINICAL & TRANSLATIONAL ONCOLOGY. 2017 ; Vol. 19. pagg. 651-657.
@article{2718b6244d254598b3044c09f50b5b23,
title = "Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer",
abstract = "Prostate cancer is the second most diagnosed cancer in males in the world. Plasma quantification of prostate-specific antigen substantially improved the early detection of prostate cancer, but still lacks the required specificity. Clinical management of prostate cancer needs advances in the development of new non-invasive biomarkers, ameliorating current diagnosis and prognosis and guiding therapeutic decisions. microRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the post-transcriptional level. These miRNAs are expressed in the cells and are also present in cell-derived extracellular vesicles such as exosomes. Exosomes have been shown to act as mediators for cell to cell communication because of the regulatory functions of their content. High levels of exosomes are found in several body fluids from cancer patients and could be a potential source of non-invasive biomarkers. In this review, we summarize the diagnostic and prognostic utility of exosomal miRNAs in prostate cancer.",
author = "Marco Giallombardo and {Reclusa Asiain}, Pablo and Christian Rolfo and Crispi and Camps and Marco Giallombardo and Anna Valentino and Patrick Pauwels and Rafael Sirera and Pablo Reclusa",
year = "2017",
language = "English",
volume = "19",
pages = "651--657",
journal = "Clinical and Translational Oncology",
issn = "1699-048X",
publisher = "Springer-Verlag Italia",

}

TY - JOUR

T1 - Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer

AU - Giallombardo, Marco

AU - Reclusa Asiain, Pablo

AU - Rolfo, Christian

AU - Crispi, null

AU - Camps, null

AU - Giallombardo, Marco

AU - Valentino, Anna

AU - Pauwels, Patrick

AU - Sirera, Rafael

AU - Reclusa, Pablo

PY - 2017

Y1 - 2017

N2 - Prostate cancer is the second most diagnosed cancer in males in the world. Plasma quantification of prostate-specific antigen substantially improved the early detection of prostate cancer, but still lacks the required specificity. Clinical management of prostate cancer needs advances in the development of new non-invasive biomarkers, ameliorating current diagnosis and prognosis and guiding therapeutic decisions. microRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the post-transcriptional level. These miRNAs are expressed in the cells and are also present in cell-derived extracellular vesicles such as exosomes. Exosomes have been shown to act as mediators for cell to cell communication because of the regulatory functions of their content. High levels of exosomes are found in several body fluids from cancer patients and could be a potential source of non-invasive biomarkers. In this review, we summarize the diagnostic and prognostic utility of exosomal miRNAs in prostate cancer.

AB - Prostate cancer is the second most diagnosed cancer in males in the world. Plasma quantification of prostate-specific antigen substantially improved the early detection of prostate cancer, but still lacks the required specificity. Clinical management of prostate cancer needs advances in the development of new non-invasive biomarkers, ameliorating current diagnosis and prognosis and guiding therapeutic decisions. microRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the post-transcriptional level. These miRNAs are expressed in the cells and are also present in cell-derived extracellular vesicles such as exosomes. Exosomes have been shown to act as mediators for cell to cell communication because of the regulatory functions of their content. High levels of exosomes are found in several body fluids from cancer patients and could be a potential source of non-invasive biomarkers. In this review, we summarize the diagnostic and prognostic utility of exosomal miRNAs in prostate cancer.

UR - http://hdl.handle.net/10447/238070

M3 - Article

VL - 19

SP - 651

EP - 657

JO - Clinical and Translational Oncology

JF - Clinical and Translational Oncology

SN - 1699-048X

ER -